1-2 of 2
Tarec C. El-Galaly
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Time to progression of disease and outcomes with second-line BTK inhibitors in relapsed/refractory mantle cell lymphoma

Diego Villa, Aixiang Jiang, Carlo Visco, Nicola Crosbie, Rory McCulloch, Michael J. Buege, Anita Kumar, David A. Bond, Jonas Paludo, Matthew J. Maurer, Gita Thanarajasingam, Katharine L. Lewis, Chan Y. Cheah, Joachim Baech, Tarec C. El-Galaly, Laveniya Kugathasan, David W. Scott, Alina S. Gerrie, David Lewis
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4576–4585.
https://doi.org/10.1182/bloodadvances.2023009804
Published: 2023
Includes: Supplemental data
Journal Articles

Incidence and time trends of second primary malignancies after non-Hodgkin lymphoma: a Swedish population-based study

Joel Joelsson, Tove Wästerlid, Richard Rosenquist, Lasse Hjort Jakobsen, Tarec C. El-Galaly, Karin E. Smedby, Sandra Eloranta
Journal: Blood Advances
Blood Adv (2022) 6 (8): 2657–2666.
https://doi.org/10.1182/bloodadvances.2021006369
Published: 2022
Includes: Supplemental data